These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32027461)

  • 1. Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: A systematic review.
    d'Izarny-Gargas T; Durrbach A; Zaidan M
    Am J Transplant; 2020 Sep; 20(9):2457-2465. PubMed ID: 32027461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature.
    Abdel-Wahab N; Safa H; Abudayyeh A; Johnson DH; Trinh VA; Zobniw CM; Lin H; Wong MK; Abdelrahim M; Gaber AO; Suarez-Almazor ME; Diab A
    J Immunother Cancer; 2019 Apr; 7(1):106. PubMed ID: 30992053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell Carcinoma.
    Tsung I; Worden FP; Fontana RJ
    Oncologist; 2021 Feb; 26(2):133-138. PubMed ID: 32969143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature.
    Kumar V; Shinagare AB; Rennke HG; Ghai S; Lorch JH; Ott PA; Rahma OE
    Oncologist; 2020 Jun; 25(6):505-514. PubMed ID: 32043699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Checkpoint Inhibitors in Organ Transplant Patients.
    Kittai AS; Oldham H; Cetnar J; Taylor M
    J Immunother; 2017 Sep; 40(7):277-281. PubMed ID: 28719552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune checkpoint blockers in solid organ transplant recipients and cancer: the INNOVATED cohort.
    Remon J; Auclin E; Zubiri L; Schneider S; Rodriguez-Abreu D; Minatta N; Gautschi O; Aboubakar F; Muñoz-Couselo E; Pierret T; Rothschild SI; Cortiula F; Reynolds KL; Thibault C; Gavralidis A; Blais N; Barlesi F; Planchard D; Besse BMD
    ESMO Open; 2024 May; 9(5):103004. PubMed ID: 38653155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Checkpoint Inhibitors in Transplantation-A Case Series and Comprehensive Review of Current Knowledge.
    Delyon J; Zuber J; Dorent R; Poujol-Robert A; Peraldi MN; Anglicheau D; Lebbe C
    Transplantation; 2021 Jan; 105(1):67-78. PubMed ID: 32355121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of solid organ transplant recipients with metastatic cancers who are treated with immune checkpoint inhibitors: A single-center analysis.
    Owoyemi I; Vaughan LE; Costello CM; Thongprayoon C; Markovic SN; Herrmann J; Otley CC; Taner T; Mangold AR; Leung N; Herrmann SM; Kukla A
    Cancer; 2020 Nov; 126(21):4780-4787. PubMed ID: 32786022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune checkpoint inhibitors in kidney transplantation.
    Alzahrani N; Al Jurdi A; Riella LV
    Curr Opin Organ Transplant; 2023 Feb; 28(1):46-54. PubMed ID: 36579684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplant rejections associated with immune checkpoint inhibitors: A pharmacovigilance study and systematic literature review.
    Nguyen LS; Ortuno S; Lebrun-Vignes B; Johnson DB; Moslehi JJ; Hertig A; Salem JE
    Eur J Cancer; 2021 May; 148():36-47. PubMed ID: 33721705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bad and the Good News on Cancer Immunotherapy: Implications for Organ Transplant Recipients.
    Maggiore U; Pascual J
    Adv Chronic Kidney Dis; 2016 Sep; 23(5):312-316. PubMed ID: 27742386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune checkpoint inhibitors in kidney transplant recipients: a multicentre, single-arm, phase 1 study.
    Carroll RP; Boyer M; Gebski V; Hockley B; Johnston JK; Kireta S; Tan H; Taylor A; Wyburn K; Zalcberg JR
    Lancet Oncol; 2022 Aug; 23(8):1078-1086. PubMed ID: 35809595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging Issue.
    Aguirre LE; Guzman ME; Lopes G; Hurley J
    Oncologist; 2019 Mar; 24(3):394-401. PubMed ID: 30413665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune checkpoint inhibitor therapy in solid organ transplant recipients: A patient-centered systematic review.
    Fisher J; Zeitouni N; Fan W; Samie FH
    J Am Acad Dermatol; 2020 Jun; 82(6):1490-1500. PubMed ID: 31302190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment.
    Hurkmans DP; Verhoeven JGHP; de Leur K; Boer K; Joosse A; Baan CC; von der Thüsen JH; van Schaik RHN; Mathijssen RHJ; van der Veldt AAM; Hesselink DA
    J Immunother Cancer; 2019 Jul; 7(1):182. PubMed ID: 31300068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Checkpoint Inhibitor Use in Solid Organ Transplant Recipients: A Systematic Review.
    Portuguese AJ; Tykodi SS; Blosser CD; Gooley TA; Thompson JA; Hall ET
    J Natl Compr Canc Netw; 2022 Apr; 20(4):406-416.e11. PubMed ID: 35390767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Checkpoint Inhibitors in Recipients of Renal Allografts.
    Venkataraman K; Salehi T; Carroll RP
    Semin Nephrol; 2024 Jan; 44(1):151500. PubMed ID: 38548484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates.
    Kawashima S; Joachim K; Abdelrahim M; Abudayyeh A; Jhaveri KD; Murakami N
    Korean J Transplant; 2022 Jun; 36(2):82-98. PubMed ID: 35919193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor Outcomes With the Use of Checkpoint Inhibitors in Kidney Transplant Recipients.
    Venkatachalam K; Malone AF; Heady B; Santos RD; Alhamad T
    Transplantation; 2020 May; 104(5):1041-1047. PubMed ID: 31415036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of programmed cell death-1 inhibitor therapy for advanced-stage cutaneous squamous cell carcinoma in solid-organ transplant recipients.
    Hanania HL; Lewis DJ
    J Dermatolog Treat; 2022 Dec; 33(8):3119-3126. PubMed ID: 36018250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.